One in five (19%) firms over 200 workers covers GLP-1 agonists for weight loss with more coverage among larger firms One-in-five (19%) firms with 200 or more workers, including 43% of firms with 5,000 or more workers, cover GLP-1 drugs for weight loss in their largest health plan in 2025
The study was a retrospective matched cohort study with 16,827 patients evaluated by neuro-ophthalmologists from 2017 to 2023
This distinction is central to the ongoing debate regarding the long-term gold standard
These results imply that A
Agilent Technologies, Palo Alto, USA)
Tonic+ Blanchisseur Concentr, une formule concentre enrichie au Glutathion et la Kenacol, conue pour prendre soin de la peau et lui apporter un aspect plus lumineux et uniforme